Exchange: NASDAQ·Updated 04:15 PM EST

QCLS News

News
all
press releases
QCLS stock had surged 11% before declining 13% in the first half hour of trade on Wednesday.
Stocktwits
QCLS shares rallied after American pharma investor Martin Shkreli said on X that he had bought the stock, giving it a near-term price target of $100.
Stocktwits
PharmaCyte noted that it now has approximately $25 million in marketable securities, in addition to roughly $20 million in cash.
Stocktwits
The stock has garnered significant retail attention in recent days following the firm's announcement of a shift in focus to high-performance computing tailored for the cryptocurrency space.
Stocktwits

Advertisement|Remove ads.